Yahoo
NasdaqGS - Delayed Quote USD

Bruker Corporation (BRKR)

59.41 +0.39 (+0.66%)
At close: September 3 at 4:00:01 PM EDT
60.00 +0.59 (+0.99%)
Pre-Market: 4:36:33 AM EDT
Trade Bruker on Coinbase
Dividend
BRKR announced a cash dividend of $0.05 with an ex-date of Sep. 21, 2026
Chart Range Bar
Loading chart for BRKR
  • Previous Close 59.02
  • Open 59.82
  • Bid 56.07 x 100
  • Ask 61.69 x 100
  • Day's Range 57.47 - 60.29
  • 52 Week Range 29.84 - 65.30
  • Volume 1,208,639
  • Avg. Volume 2,235,574
  • Market Cap (intraday) 9.052B
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.70
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 0.20 (0.34%)
  • Ex-Dividend Date Sep 21, 2026
  • 1y Target Est 58.75

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

www.bruker.com

11,085

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BRKR
26.41%
S&P 500 (^GSPC)
13.18%

1-Year Return

BRKR
103.42%
S&P 500 (^GSPC)
20.15%

3-Year Return

BRKR
8.90%
S&P 500 (^GSPC)
71.57%

5-Year Return

BRKR
33.87%
S&P 500 (^GSPC)
70.83%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 838.5M
Earnings -52M
Profit Margin -6.20%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
800M
-6.0%
-4.0%
-2.0%
0.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

40.00 Low
58.75 Average
59.41 Current
70.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/5/2026
Analyst Citigroup
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 60 -> 53

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    8.54B

  • Enterprise Value

    10.14B

  • Trailing P/E

    --

  • Forward P/E

    15.22

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.44

  • Price/Book (mrq)

    3.58

  • Enterprise Value/Revenue

    2.90

  • Enterprise Value/EBITDA

    37.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.04%

  • Return on Assets (ttm)

    3.14%

  • Return on Equity (ttm)

    -3.00%

  • Revenue (ttm)

    3.5B

  • Net Income Avi to Common (ttm)

    -106.9M

  • Diluted EPS (ttm)

    -0.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    184.9M

  • Total Debt/Equity (mrq)

    76.16%

  • Levered Free Cash Flow (ttm)

    179.94M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

59.41 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $59.00

    BRUKER CORP has an Investment Rating of HOLD; a target price of $59.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • What does Argus have to say about BRKR?

    BRUKER CORP has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • What does Argus have to say about BRKR?

    BRUKER CORP has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $60.00

    BRUKER CORP has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: